Bionano Genomics Inc expected to post a loss of 97 cents a share - Earnings Preview

Bionano Genomics

30/10/2023 11:37

* Bionano Genomics Inc  BNGO.OQ   BNGO.O  is expected
to show a
rise in quarterly revenue when it reports  results 
    * The San Diego California-based  company is expected to
report  a
25.8% increase in revenue to $9.083 million from $7.22 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. The company's guidance on October 11 2023,
for the period ended September 30, was for revenue between $9.10
million and $9.30 million.
    * ​Refinitiv's mean analyst estimate for Bionano Genomics
Inc is
for a loss of 97 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $9​, above​ its last closing price of $1.26. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -1.00       -1.03      -1.24     Missed  -20
 Mar. 31 2023  -1.10       -1.10      -1.20     Missed  -9.1
 Dec. 31 2022  -1.14       -1.10      -1.30     Missed  -18.2​
 Sep. 30 2022  -1.18       -1.15      -1.10     Beat    4.3
 ​​Jun.        -1.03       -0.91      -1.10     Missed  -20.4
 30 2022                                                
 Mar. 31 2022  -0.87       -0.75      -1.10     Missed  -46.7​
 Dec. 31 2021  -0.64       -0.65      -0.80     Missed  -23.6
 Sep. 30 2021  -0.57       -0.57      -0.74     Missed  -30.6
 This summary was machine generated October 30 at 11:37 GMT.  All
figures in US dollars  unless otherwise stated